When Medicine Meets Mandates: The Boyce Family’s Battle and the Dark Side of Pediatric Cancer Care
Originally published: 2025-11-01
In the quiet suburbs of Charlotte, North Carolina, a family’s fight for their son’s well-being has ignited a national debate on medical freedom, parental autonomy, and the role of the state in healthcare decisions. The Boyce case, unfolding in real-time as of late October 2025, serves as a stark reminder of how suspicions in a hospital room can escalate into threats of child removal. But this isn’t an isolated incident, it’s part of a troubling pattern where parents opting for integrative approaches to cancer treatment find themselves battling not just the disease, but the system itself.
The Boyce Case: Too Healthy to Be True?
Shelley and Shawn Boyce’s 8-year-old son, Judah, was diagnosed with acute lymphoblastic leukemia (ALL) in early 2024. Following standard protocol at Novant Health Hemby Children’s Hospital, affiliated with St. Jude, Judah began chemotherapy. But the Boyces didn’t stop there, they incorporated supportive therapies like hyperbaric oxygen, red-light therapy, supplements, and a nutrient-rich diet from their organic farm to bolster his immune system and counteract chemo’s harsh effects.
By October 2025, Judah was 20 months into remission and just months from completing his 2.5-year regimen. His bloodwork showed robust neutrophil counts, and he exhibited few typical side effects like nausea or fatigue. Doctors, however, grew suspicious.
“Why isn’t he sicker? What are you doing?” – Doctors questioning the Boyce family, as recounted by Shelley Boyce.
Despite evidence of compliance, including blood tests confirming chemo drugs in his system and nightly dosing documented by a private nurse, the clinic filed a CPS referral on October 17, 2025, alleging medical neglect. CPS visited the home, escalating fears of Judah (and possibly his siblings) being removed. Advocates like Maureen Steele of the American Made Foundation call it “tyranny in a lab coat,” highlighting how CPS interventions can be incentivized by federal funding.
The Boyces, now fundraising for legal fees via GiveSendGo, argue this is retaliation for questioning protocols and achieving unexpectedly positive results. As of October 30, 2025, the case remains unresolved, with no new public developments beyond ongoing petitions and media scrutiny.
Daniel Hauser: Fleeing for Faith and Natural Remedies
In 2009, 13-year-old Daniel Hauser from Minnesota was diagnosed with Hodgkin’s lymphoma. After one chemo round, his parents, influenced by the Nemenhah Band’s natural healing philosophy, halted treatment.
“I know many people around here who have had cancer, they did the chemo, it would come back... Chemo isn’t foolproof.” – Anthony Hauser, Daniel’s father.
A judge ordered chemo, prompting the family to flee to Mexico. They returned under threat of arrest, and Daniel completed treatment, surviving. The case underscored the tension between religious beliefs and state-mandated care.
Katie Wernecke: Radiation Refusal and State Seizure
Texas teen Katie Wernecke, 12, faced Hodgkin’s lymphoma in 2005. Her parents agreed to chemo but rejected radiation, fearing long-term harm, and sought high-dose vitamin C instead.
“I think they should treat her for what her body calls for and not standard protocol. Nobody will look at that... Her body is not standard, and her cancer is not standard.” – Michele Wernecke, Katie’s mother.
CPS seized Katie (and briefly her siblings), forcing radiation. After appeals, the family regained custody; Katie survived but faced recurrence in 2007.
Starchild Abraham Cherrix: Herbs Over Harsh Treatment
At 16, Virginia’s Abraham Cherrix refused further chemo for Hodgkin’s lymphoma in 2006, choosing herbal remedies at a Mexican clinic after initial treatment’s side effects.
“I truly believe that this massive dose of chemo and radiation would finish me off completely.” – Abraham Cherrix.
Courts initially ordered treatment, but appeals allowed alternatives under supervision. Cherrix survived, later crediting a blend of therapies, including stem cells in adulthood.
Parker Jensen: Diagnostic Doubts and a Flight to Freedom
Utah’s 12-year-old Parker Jensen had a tumor removed in 2003, diagnosed as Ewing’s sarcoma. His parents questioned the diagnosis and refused chemo.
“Everything we’ve ever wanted, we have.” – Daren Jensen, Parker’s father, reflecting on family priorities post-ordeal.
The state pursued neglect charges; the family fled. Utah dropped the case, and Parker, untreated conventionally, remains healthy at 22.
Sarah Hershberger: Amish Values vs. Hospital Authority
Ohio’s 10-year-old Amish girl Sarah Hershberger started chemo for lymphoblastic lymphoma in 2013 but stopped due to side effects, turning to natural remedies.
“I know how she looks isn’t really an indication of whether she has cancer, but she’s looking very healthy.” – Judge Kevin Dunn, ending oversight in 2015.
The hospital won guardianship; the family fled abroad. Appeals ended it, and Sarah reportedly became cancer-free without full chemo.
Cassandra Callender: Forced Chemo and a Tragic Return
Connecticut’s 17-year-old Cassandra Callender refused chemo for Hodgkin’s lymphoma in 2015, favoring alternatives.
“She basically said, ‘Ma, nobody was here for me.’ And she said, ‘Every time I tried and tried, I get kicked in the gut.’” – Jackie Fortin, Cassandra’s mother, after her death.
The state forced treatment; her cancer returned, and she died in 2018 at 22, despite later resuming care.
Noah McAdams: CBD Over Chemo in Florida
Florida’s 3-year-old Noah McAdams began chemo for ALL in 2019, but his parents halted it for CBD and herbs.
“This is why I fought so hard against chemotherapy.” – Noah McAdams’ parents, during court proceedings.
They fled; a judge ordered resumed treatment. Parents regained custody after compliance; Noah completed chemo successfully.
Lessons from the Frontlines: Balancing Rights and Survival
These cases reveal a recurring theme: Courts often invoke the “best interest of the child” to enforce conventional treatments with high success rates (80-90% for many childhood lymphomas and leukemias). Yet outcomes vary, some survive without full protocols, others don’t. The Boyce saga, with its focus on a child “too healthy,” questions if success outside rigid guidelines invites scrutiny rather than celebration.
As Steele notes, CPS can become a “money-making racket.” Reforms for transparency and parental input are needed to prevent overreach. For families like the Boyces, the fight continues, not just against cancer, but for the right to heal on their terms.
